The Modified Pancreatitis Activity Scoring System Shows Distinct Trajectories in Acute Pancreatitis: An International Study.
Acute Pancreatitis
Disease Activity
PASS
Severity
Journal
Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association
ISSN: 1542-7714
Titre abrégé: Clin Gastroenterol Hepatol
Pays: United States
ID NLM: 101160775
Informations de publication
Date de publication:
06 2022
06 2022
Historique:
received:
17
07
2021
revised:
09
09
2021
accepted:
14
09
2021
pubmed:
21
9
2021
medline:
10
5
2022
entrez:
20
9
2021
Statut:
ppublish
Résumé
The aims of this study were to: (1) assess the performance of the Pancreatitis Activity Scoring System (PASS) in a large intercontinental cohort of patients with acute pancreatitis (AP); and (2) investigate whether a modified PASS (mPASS) yields a similar predictive accuracy and produces distinct early trajectories between severity subgroups. Data was prospectively collected through the Acute Pancreatitis Patient Registry to Examine Novel Therapies In Clinical Experience (APPRENTICE) consortium (2015-2018) involving 22 centers from 4 continents. AP severity was categorized per the revised Atlanta classification. PASS trajectories were compared between the three severity groups using the generalized estimating equations model. Four mPASS models were generated by modifying the morphine equivalent dose (MED), and their trajectories were compared. A total of 1393 subjects were enrolled (median age, 49 years; 51% males). The study cohort included 950 mild (68.2%), 315 (22.6%) moderately severe, and 128 (9.2%) severe AP. Mild cases had the lowest PASS at each study time point (all P < .001). A subset of patients with outlier admission PASS values was identified. In the outlier group, 70% of the PASS variation was attributed to the MED, and 66% of these patients were from the United States centers. Among the 4 modified models, the mPASS-1 (excluding MED from PASS) demonstrated high performance in predicting severe AP with an area under the receiver operating characteristic curve of 0.88 (vs area under the receiver operating characteristic of 0.83 in conventional PASS) and produced distinct trajectories with distinct slopes between severity subgroups (all P < .001). We propose a modified model by removing the MED component, which is easier to calculate, predicts accurately severe AP, and maintains significantly distinct early trajectories.
Sections du résumé
BACKGROUND & AIMS
The aims of this study were to: (1) assess the performance of the Pancreatitis Activity Scoring System (PASS) in a large intercontinental cohort of patients with acute pancreatitis (AP); and (2) investigate whether a modified PASS (mPASS) yields a similar predictive accuracy and produces distinct early trajectories between severity subgroups.
METHODS
Data was prospectively collected through the Acute Pancreatitis Patient Registry to Examine Novel Therapies In Clinical Experience (APPRENTICE) consortium (2015-2018) involving 22 centers from 4 continents. AP severity was categorized per the revised Atlanta classification. PASS trajectories were compared between the three severity groups using the generalized estimating equations model. Four mPASS models were generated by modifying the morphine equivalent dose (MED), and their trajectories were compared.
RESULTS
A total of 1393 subjects were enrolled (median age, 49 years; 51% males). The study cohort included 950 mild (68.2%), 315 (22.6%) moderately severe, and 128 (9.2%) severe AP. Mild cases had the lowest PASS at each study time point (all P < .001). A subset of patients with outlier admission PASS values was identified. In the outlier group, 70% of the PASS variation was attributed to the MED, and 66% of these patients were from the United States centers. Among the 4 modified models, the mPASS-1 (excluding MED from PASS) demonstrated high performance in predicting severe AP with an area under the receiver operating characteristic curve of 0.88 (vs area under the receiver operating characteristic of 0.83 in conventional PASS) and produced distinct trajectories with distinct slopes between severity subgroups (all P < .001).
CONCLUSION
We propose a modified model by removing the MED component, which is easier to calculate, predicts accurately severe AP, and maintains significantly distinct early trajectories.
Identifiants
pubmed: 34543736
pii: S1542-3565(21)00978-2
doi: 10.1016/j.cgh.2021.09.014
pmc: PMC9060638
mid: NIHMS1801101
pii:
doi:
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Langues
eng
Sous-ensembles de citation
IM
Pagination
1334-1342.e4Subventions
Organisme : NCI NIH HHS
ID : T32 CA186873
Pays : United States
Organisme : NIDDK NIH HHS
ID : U01 DK108323
Pays : United States
Informations de copyright
Copyright © 2022 AGA Institute. Published by Elsevier Inc. All rights reserved.
Références
J Biomed Inform. 2009 Apr;42(2):377-81
pubmed: 18929686
Gut. 2013 Jan;62(1):102-11
pubmed: 23100216
Ann Gastroenterol. 2017;30(1):106-113
pubmed: 28042246
Crit Care Med. 1995 Oct;23(10):1638-52
pubmed: 7587228
Clin Transl Gastroenterol. 2017 Dec 7;8(12):e129
pubmed: 29215631
Clin Gastroenterol Hepatol. 2009 Nov;7(11):1247-51
pubmed: 19686869
J Gastroenterol Hepatol. 2021 Sep;36(9):2416-2423
pubmed: 33604947
Rev Esp Enferm Dig. 2013 Feb;105(2):84-92
pubmed: 23659507
Gut. 2021 Jan;70(1):139-147
pubmed: 32245906
J Hosp Med. 2014 Feb;9(2):73-81
pubmed: 24227700
N Engl J Med. 2010 Nov 18;363(21):1981-5
pubmed: 21083382
United European Gastroenterol J. 2021 Mar;9(2):139-149
pubmed: 33871926
J Clin Gastroenterol. 2019 Sep;53(8):e328-e333
pubmed: 30036238
Am J Gastroenterol. 2018 May;113(5):755-764
pubmed: 29545634
Clin Gastroenterol Hepatol. 2020 Jun;18(7):1567-1575.e2
pubmed: 31712075
Gastroenterology. 2013 Jun;144(6):1252-61
pubmed: 23622135
Pancreatology. 2020 Apr;20(3):325-330
pubmed: 32107193
Am J Gastroenterol. 2012 Aug;107(8):1146-50
pubmed: 22858994
Ann Intern Med. 2017 Jun 20;166(12):883-892
pubmed: 28505667
Am J Gastroenterol. 2017 Jul;112(7):1144-1152
pubmed: 28462914
Gastroenterology. 2018 Mar;154(4):1103-1139
pubmed: 29421596